Kidney Failure

Digital engagement tools effectively identified patients who needed shared and informed decision-making and helped prepare those who required kidney replacement treatments, according to results of a mixed methods study.

Lumasiran, an RNA interference therapeutic that suppresses glycolate oxidase and reduces hepatic oxalate production, exhibited an acceptable safety and efficacy profile in patients with primary hyperoxaluria type 1, according to a study.

Presentations focused on educating patients about their kidney failure options required better practices to improve content gaps, health literacy and patient communication with nephrologists, according to a study.

Compared with patients who had chronic kidney disease alone, those who also had pulmonary hypertension were at greater risk for a variety of adverse outcomes, according to study findings.

Differing from individuals without kidney disease, higher coronary artery calcification scores in patients on dialysis were not associated with an increased risk for coronary artery stenosis.

Patients on maintenance dialysis in Taiwan were employed for fewer years during their lifetime than individuals from the general population without kidney failure.

Applying a risk progression classification system to patients with a sepsis-associated kidney injury can aid nephrologists in predicting long-term kidney outcomes, results show.

Similar to how emergency departments have teams ready to treat patients after cardiac arrest or stroke, a speaker argued it is equally necessary to have interventional teams for patients who develop rapid kidney failure.

Patients with sickle cell disease-related kidney failure experienced similar reductions in mortality following transplantation as those whose kidney failure stemmed from other causes, according to researchers from Johns Hopkins.

Adding to its resources on rare diseases, The American Kidney Fund has launched an education and awareness campaign on primary hyperoxaluria.